title: Pooled patient level data are better suited than study level data to investigate the link between dipeptidyl peptidase-4 inhibitors and the risk of heart failure in type 2 diabetes.
authors.affiliation: Food and Drug Administration, 10993 New Hampshire Avenue, Silver Spring, MD 20993, USA.
authors.forename: Tejas
authors.initials: T
authors.lastname: Patel
authors.affiliation: Food and Drug Administration, 10993 New Hampshire Avenue, Silver Spring, MD 20993, USA.
authors.forename: Bereket
authors.initials: B
authors.lastname: Tesfaldet
authors.affiliation: Division of Cardiovascular Medicine, Department of Internal Medicine, Howard University Hospital, Washington, DC, USA.
authors.forename: Charu
authors.initials: C
authors.lastname: Gandotra
mesh_terms: D003627:Data Interpretation, Statistical; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects*; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D015201:Meta-Analysis as Topic; D012196:Review Literature as Topic; D018570:Risk Assessment / Q000379:methods*
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents